Brief: Cytocom Inc Reports Q2 Loss Per Share Of $0.04 Excluding Minority Interests
16/08/2021 12:35
Aug 16 (Reuters) - Cytocom Inc CBLI.O :
* CYTOCOM, INC. REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS
* Q2 LOSS PER SHARE $0.04 EXCLUDING MINORITY INTERESTS
* CLEVELAND BIOLABS INC - DID NOT GENERATE REVENUE DURING Q2
2021
VERSUS $0.06 MILLION IN REVENUE FOR Q2 2020
Source text for Eikon: ID:nPn85QKNMa
Further company coverage: CBLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc